FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileResonance Health Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
RHT.AX
Resonance Health Limited Stock AnalysisComprehensive stock analysis for Resonance Health Limited (RHT.AX) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisRHT.AX
RHT.AX
Resonance Health Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
RHT.AX
  1. Home
  2. Stocks
  3. Resonance Health Limited

Resonance Health Limited

🇦🇺RHT.AX•ASX

Resonance Health Limited

🇦🇺RHT.AX•ASX
P/E ratio
23.75

Your view on RHT.AX

P/E
23.75
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Resonance Health Limited

Industry
Medical - Healthcare Information Services
Sector
Healthcare
CEO
Andrew Duncan Harrison
Headquarters
141 Burswood Road, Burswood, WA, AU
Industry
Medical - Healthcare Information Services
Sector
Healthcare
CEO
Andrew Duncan Harrison
Headquarters
141 Burswood Road, Burswood, WA, AU
Description

Resonance Health Limited is a global provider of healthcare technology and services, specializing in the design, development, and production of software-as-medical devices. The company serves markets across the Asia Pacific, Americas, Europe, Middle East, and Africa.

Its portfolio of non-invasive, MRI-based diagnostic tools includes FerriScan, a system for quantifying liver iron concentration (LIC); FerriSmart, leveraging artificial intelligence (AI) for automated, real-time assessment of LIC; HepaFat-AI, an AI-driven solution for real-time, multi-metric liver fat quantification; CardiacT2, which provides dual analysis in conjunction with FerriScan to evaluate cardiac iron accumulation; HepaFat-Scan, a non-invasive MRI method for assessing liver fat within tissue; and LiverSmart, a comprehensive non-invasive MRI device integrating FerriSmart and HepaFat-AI for a unified report.

The company further extends its offerings to include quantitative imaging measurements and Contract Research Organization (CRO) services, encompassing rigorous image analysis, imaging charter development, robust project and data management, proactive issue resolution, site tracking with clinical trial progress reports, and streamlined data flow coordination.

They also provide comprehensive biomarker services, covering analysis of blood, urine, and protein analytes, alongside RNA, DNA, and genotyping.

Their support for multinational and multicenter clinical trials extends to protocol development, subject inclusion/exclusion criteria assessment, dose modification strategies, new therapy safety profile evaluations, and establishing primary and secondary endpoints for drug efficacy.

Additionally, they supply phantoms crucial for MRI machine calibration. Its client base includes clinicians, who utilize their solutions for managing human diseases, and pharmaceutical and therapeutic companies engaged in clinical research. Established in 1987, Resonance Health Limited maintains its headquarters in Burswood, Australia.

Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Resonance Health Limited. Starting points for Resonance Health Limited: P/E 23.8, beta 1.08 — an Medical - Healthcare Information Services name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Resonance Health Limited. Resonance Health Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Resonance Health Limited. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Resonance Health Limited. Resonance Health Limited has reported as a listed company since 2000. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold RHT.AX18 companies
Compare RHT.AX with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis
Peer companies
TickerTypeCompanySectorIndustry
AT1.AXAtomo Diagnostics LimitedHealthcareMedical - Devices—
ENL.AXEnlitic, Inc.HealthcareMedical - Healthcare Information Services—
HMD.AXHeraMED LimitedHealthcareMedical - Devices—
ICR.AXIntelicare Holdings LimitedHealthcareMedical - Healthcare Information Services—
IDT.AXIDT Australia LimitedHealthcareDrug Manufacturers - Specialty & Generic—
IMC.AXImmuron LimitedHealthcareBiotechnology—
IME.AXImExHS LimitedHealthcareMedical - Diagnostics & Research—
More Medical - Healthcare Information Services companies
TickerTypeCompanySectorExchangeMkt cap
HTFLHeartflow, Inc. Common StockHealthcareNASDAQ$4.0B
IBXGiBX Group, Inc.HealthcareOTC$1,975
ICCOInterCare DX, Inc.HealthcareOTC$1,990
IGRWInteractive Health NetworkHealthcareOTC$39,815
LFCOFLift & Co. Corp.HealthcareOTC$71,601
LFMDLifeMD, Inc.HealthcareNASDAQ$82.2M
LFMDPLifeMD, Inc.HealthcareNASDAQ$131.2M
LVCELiveCare, Inc.HealthcareOTC$381,860
LYNX.CNLynx Global Digital Finance CorporationHealthcareCNQ$6.4M
M7T.AXMach7 Technologies LimitedHealthcareASX—
MDBIFTrivarX LimitedHealthcareOTC$1.6M
Open Comparable Analysis
Ownership & News

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Resonance Health Limited. Coverage tracks Resonance Health Limited within Medical - Healthcare Information Services (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Resonance Health Limited.

RHT.AX AnalysisGood
Past
5
Growth
5
Health
4
Profit
3
Value
1